Large-scale testing (Phase 3)Study completedNCT03976102
What this trial is testing
Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma
Who this might be right for
Follicular Lymphoma
Dr. Reddy's Laboratories Limited 317